3D bioprinting technology developed for cancer immunotherapy
A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time.
Jul 13, 2023
0
57
A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time.
Jul 13, 2023
0
57
CAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood cancers, may enhance the effectiveness of surgery for solid tumors, according to a preclinical study from researchers in the ...
Jan 11, 2023
0
71
Researchers have been experimenting with different ways to deliver genes to the brain to treat central nervous system diseases and tumors. One of the obstacles, however, is the ability to penetrate the blood-brain barrier ...
Oct 18, 2022
0
68
The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.
May 4, 2022
0
107
Purdue University researchers in the College of Pharmacy and College of Engineering are developing a patent-pending treatment that could impact millions of American lives each year.
Apr 25, 2022
0
803
A gene-silencing therapy protected against Zika virus transmission from pregnant mice to the mouse fetuses, finds a study published November 10th in the journal Molecular Therapy. The treatment, which harnesses nanoparticles ...
Nov 10, 2021
0
22
Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in multiple organs of the body, have limited treatment options. A team led by investigators at Massachusetts ...
Jan 9, 2021
0
124
As cancer treatment gets more sophisticated, we need more refined drug delivery systems that can simultaneously deliver multiple drugs with different chemical makeups.
May 16, 2019
0
205
Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large ...
Jan 29, 2024
0
0
Researchers have developed a wearable optical device for early detection of hemorrhage during labor or after childbirth. This serious heavy bleeding can be hard to detect before it becomes an emergency and accounts for almost ...
Sep 21, 2023
0
13